Trientine tetrahydrochloride is used to treat Wilson’s disease, a condition where excess copper accumulates in the body. It works as a copper-chelating agent, helping remove copper by increasing its excretion in urine. This reduces the risk of liver damage, neurological issues, and other complications from copper buildup. It is an alternative for patients who are intolerant to penicillamine or trientine dihydrochloride. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Triethylenetetramine tetrahydrochloride, 3, 6-Diazaoctane-1 and 8-diamine tetrahydrochloride. Its PubChem CID is 71434.
Trientine tetrahydrochloride
| CAS No | 4961-40-4 |
|---|---|
| Molecular Formula | C6H22Cl4N4 |
| Molecular Weight | 292.1 g/mol |
| Synonyms | N’-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;tetrahydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Trientine tetrahydrochloride is used to treat Wilson’s disease, a condition where excess copper accumulates in the body. It works as a copper-chelating agent, helping remove copper by increasing its excretion in urine.
The listed CAS number is 4961-40-4.
The listed molecular formula is C6H22Cl4N4.
The listed molecular weight is 292.1 g/mol.
N’-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;tetrahydrochloride.
The source lists Triethylenetetramine tetrahydrochloride, 3, 6-Diazaoctane-1 and 8-diamine tetrahydrochloride.